Literature DB >> 21175803

Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma.

Guang-Jun Jing1, Dong-Hui Xu, Song-Lin Shi, Qi-Fu Li, San-Ying Wang, Fu-Yun Wu, Hai-Yan Kong.   

Abstract

BACKGROUND AND AIM: Nuclear-matrix proteins can be proteomic markers for cancer lesions. The present study aimed to determine the roles of heterogeneous nuclear ribonucleoproteins--A2 and B1 (hnRNP-A2/B1) in human gastric carcinogenesis.
METHODS: Human gastric cancer and non-cancerous tissues were collected for immunohistochemical analysis. Proteomics technique, Western blot, laser confocal microscope, and real-time quantitative reverse transcription-polymerase chain reaction were performed to determine the aberrant expression of nuclear-matrix proteins.
RESULTS: hnRNP-A2/B1 existed in the nuclear matrix of gastric cancer cells, and its expression was enhanced in human gastric cancer and decreased by hexamethylene bisacetamide. The colocalization of hnRNP-A2/B1 with c-myc, c-fos, p53, and Rb was translocated from the nucleolus to the cytoplasm during the differentiation of tumor cells.
CONCLUSIONS: hnRNP-A2/B1 affected tumor cell differentiation through interaction with oncogenes and tumor-suppressor genes, and it was overexpressed in human gastric cancer. We postulate that hnRNP-A2/B1 could serve as a biomarker for the diagnosis of human gastric cancer.
© 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175803     DOI: 10.1111/j.1440-1746.2010.06482.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer.

Authors:  Liping Dai; Jitian Li; Jun-Chieh J Tsay; Ting-An Yie; John S Munger; Harvey Pass; William N Rom; Eng M Tan; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

Review 2.  Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Authors:  Ya Lu; Xinyue Wang; Quan Gu; Juan Wang; Ying Sui; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Discov       Date:  2022-07-25

3.  hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression.

Authors:  Wei-Zhao Peng; Jin Zhao; Xin Liu; Chao-Feng Li; Shuang Si; Ren Ma
Journal:  Cancer Cell Int       Date:  2021-05-27       Impact factor: 5.722

4.  The RNA-binding protein hnRNPA2 regulates β-catenin protein expression and is overexpressed in prostate cancer.

Authors:  Jacqueline Stockley; M Eugenia M Villasevil; Colin Nixon; Imran Ahmad; Hing Y Leung; Prabhakar Rajan
Journal:  RNA Biol       Date:  2014-04-24       Impact factor: 4.652

5.  Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis.

Authors:  Peng Dai; Qin Wang; Weihua Wang; Ruirui Jing; Wei Wang; Fengqin Wang; Kazem M Azadzoi; Jing-Hua Yang; Zhen Yan
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

6.  Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.

Authors:  Yuhui Zhang; Weibin Huang; Yujie Yuan; Jin Li; Jing Wu; Jie Yu; Yulong He; Zhewei Wei; Changhua Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.